AMA/ASHP Pharmacogenomics Virtual Summit Series: Summit #1: Pharmacogenomics Landscape

p style="text-align: left;">The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Health-System Pharmacists designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity was planned in cooperation with the American Medical Association.This continuing pharmacy and medical education activity is designed for healthcare professionals interested in pharmacogenomics. The activity is meant for audiences with all knowledge levels. 

After participating in this activity, participants should be able to:

• Discuss the benefits and limitations of pharmacogenomics.
• Identify the institution perspective on the value of pharmacogenomic testing.
• Discuss the economic environment around pharmacogenomics.
• Identify an international perspective on the use of pharmacogenomics for prescribing decisions.
• Describe a patient experience navigating pharmacogenomics.
• Recognize the role of health equity in pharmacogenomics. 

• Introduction
• What Can Pharmacogenomic Testing Do?
• Institution Perspective
• Economics: Payment & Policy Landscape
• 100,000 genomes project and pharmacogenomics: UK perspective
• Patient Voice
• Health Equity
• Q&A
• Future Directions & Wrap-up 

• Moderators:
  • Mira Irons, M.D., Chief Health and Science Officer; Group Vice President, Health, Science and Ethics at the American Medical Association
  • Julie A. Johnson, Pharm.D., Dean and Distinguished Professor of Pharmacy and Medicine, University of Florida College of Pharmacy, Director, UF Health Personalized Medicine Program

• Speakers:
  • Sara Rogers, Pharm.D., BCPS, Director of Clinical Affairs, American Society of Pharmacovigilance
  • Professor Sir Munir Pirmohamed, MB ChB (Hons), PhD, FRCP, FRCP(E), FFPM, FRSB, FBPhS, FMedSci, David Weatherall Chair of Medicine and NHS Chair of Pharmacogenetics, University of Liverpool
  • Esteban G. Burchard, M.D., M.P.H., Professor in the Departments of Bioengineering and Therapeutic Sciences and Medicine, University of California San Francisco.
  • Peter J. Hulick, M.D., MMSc, FACMG, Medical Director of the Mark R. Neaman Center for Personalized Medicine, Division Head, Center for Medical Genetics, NorthShore University HealthSystem
  • Trish Brown, M.S., CGC, Director, AMR Payer Partner and Field Market Access Lead, Illumina
  • Mary V. Relling, Pharm.D., BCPS, FCCP, Member and Endowed Chair, Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital 

All planners, program chairs, presenters, reviewers and ASHP staff report no financial relationships relevant to this activity.

This activity consists of one recorded webinar presentation.  This is a 6 part series. 

Important Note – ACPE 60 Day Deadline:

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline.   After the 60 day deadline, ASHP will no longer be able to award credit for this activity.